Cerebellum’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$63K Sell
1,340
-768
-36% -$39.4K 0.29% 187
2020
Q2
$129K Buy
+2,108
New +$109K 0.09% 131
2019
Q1
Sell
-5,098
Closed -$227K 456
2018
Q4
$227K Buy
+5,098
New +$266K 0.16% 270
2018
Q3
Sell
-3,522
Closed -$172K 434
2018
Q2
$172K Buy
+3,522
New +$200K 0.29% 217
2018
Q1
Sell
-2,108
Closed -$129K 457
2017
Q4
$129K Buy
+2,108
New +$130K 0.09% 131

Other funds holding CAH

Cerebellum's CAH Position: Q3 2020 in Review

Cerebellum reduced its Cardinal Health (CAH) stake by 36% in Q3 2020, selling an estimated $39.4K and leaving 1,340 shares worth $63K. The position accounts for 0.29% of the portfolio, ranked #187.

Cerebellum first reported a position in CAH in Q4 2017 and has held it in 5 quarters since. The position peaked at $227K in Q4 2018. 741 funds tracked by Wall St. Rank hold CAH as of Q3 2020.

  • Cerebellum held 1,340 shares of Cardinal Health worth $63K as of Q3 2020.
  • Cerebellum sold 768 Cardinal Health shares in Q3 2020, an estimated $39.4K.
  • Cardinal Health made up 0.29% of Cerebellum's portfolio in Q3 2020, its #187 holding.
  • Cerebellum first reported a position in Cardinal Health in Q4 2017 and has held it in 5 quarters since.
  • Cerebellum's Cardinal Health position peaked at $227K in Q4 2018.
  • 741 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.